GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Trials & Approvals Astellas Pharma
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
Trials & Approvals Menopause
Further Clinical Trial Results Reinforce Prior Findings For Astellas’ Menopause Treatment
2022-09-05
Licensing Antibody-Drug Conjugate
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Funding Gene Therapy
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
Deals Astellas Pharma
Astellas Ditches Gene Therapies, with Losses Exceeding $390 Million
2022-04-25
Asia-Pacific Gene Therapy
Astellas Reveals Early Safety Data of Gene Therapy for Pompe Disease
2022-02-09
Asia-Pacific AAV Gene Therapy
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
Asia-Pacific Cancer
Astellas, Seagen Cancer Drug Becomes First and Only Approved ADC For Advanced Urothelial Cancer in Japan
2021-09-28
Trials & Approvals Gene Therapy
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
Deals
Astellas Makes a $440M+ Pact with Minovia to Develop Mitochondrial Cell Therapies
2021-08-03
Trials & Approvals Bladder Cancer
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
Trials & Approvals SKYLIGHT Trial
Astellas’ Non-Hormonal Drug for Hot Flashes Shows Promise in Two Phase 3 Trials
2021-02-24
Cancer
Xtandi Scores Regulatory Win in China for Non-Metastatic Castration-Resistant Prostate Cancer
2020-11-11
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Cancer
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
1 2 3
LATEST
Exosomes: What They Do and Who’s Doing What
2025-04-21
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
READ MORE
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top